-
I’m 63, retired and getting $45,000 per year. But I only have about $200,000 in my IRA and still have a mortgage. What’s my move?
Business - MarketWatch - 5 days ago -
Do I have enough money to retire? Ask yourself these 3 questions to assess whether you're ready
Business - CNBC - October 24 -
‘I own my home’: I’m 74 with $300,000 in annuities and live modestly. What should I do with my retirement savings?
Business - MarketWatch - October 24 -
‘I have few close friends’: I’m 69, retired, single and have amassed $3.6 million. What should I do with my fortune?
Business - MarketWatch - 6 days ago -
My sisters want to hide $170,000 of our mother’s money from Medicaid by adding their names to her bank account. What should I do?
Business - MarketWatch - October 24 -
'I could see my kneecap was not where it should be'
Top stories - BBC News - 5 days ago -
What we learned: We answered the big questions
Sports - ESPN - 5 days ago -
Uber ate my money, but it won’t listen when I try to complain
World - The Guardian - October 14 -
Should I take out my pension tax-free lump sum?
World - Financial Times - October 24
More from CNBC
-
Palantir shares surge on rosy revenue outlook
Business - CNBC - 4 hours ago -
Trump's tariffs could trigger 'dramatic' price spikes on clothes, furniture, warns retail group
Business - CNBC - 2 hours ago -
As the election winds down, worries of 'bond vigilantes' and inflation hit markets
Business - CNBC - 7 hours ago -
What the stock market typically does after the U.S. election, according to history
Business - CNBC - 6 hours ago -
Judge rejects request to block Elon Musk $1 million voter giveaway
Business - CNBC - 3 hours ago
Latest in Business
-
Chinese equities outperform ahead of US election
Business - Financial Times - 42 minutes ago -
Trump's tariffs could trigger 'dramatic' price spikes on clothes, furniture, warns retail group
Business - CNBC - 2 hours ago -
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago